Microbot Medical has positive surgical robot data

 Microbot Medical (Nasdaq:MBOT) today announced pivotal trial data supporting the use of its Liberty endovascular surgical robot.

The study took place at three leading U.S. medical centers: Memorial Sloan Kettering Cancer Center (New York), Baptist Hospital of Miami (Miami) and Brigham and Women’s Hospital (Boston). Dr. Francois Cornelis of Sloan Kettering presented findings at the Society of Interventional Radiology (SIR) annual meeting.

Data highlighted the feasibility of robotic endovascular procedures using Liberty. Findings also showed that using the technology significantly minimizes radiation exposure.

In 20 cases, investigators achieved successful robotic navigation, meeting the primary endpoint of the ACCESS-PVI study. The study had no adverse device events reported through the duration of follow-up, too. Investigators also reported a mean 92% relative reduction in radiation exposure with median robotic navigation time to target totaling three minutes.

The company designed Liberty for potential use in catheter-based neurovascular, cardiovascular and peripheral vascular procedures. The system includes a compact design and remote operating capabilities.

Microbot believes Liberty’s remote operation could potentially make it the first system to democratize endovascular interventional procedures. The company says it’s the world’s first single-use, fully disposable robotic system for those procedures. The company submitted Liberty to the FDA in December 2024. It expects approval and subsequent commercial activity in the second quarter of 2025.

“The ACCESS-PVI data and the performance of the system throughout the study reflect the hard work that the team has put into Liberty over the past few years,” said Harel Gadot, chair, CEO and president. “We are extremely pleased with the results in all aspects. As we shift focus to building our commercial capabilities and preparing for launch, we are confident that Liberty will be well received in the market.”

https://www.massdevice.com/microbot-medical-positive-liberty-data/